87 related articles for article (PubMed ID: 1972161)
1. Mechanisms of anti-CD4-mediated depletion and immunotherapy. A study using a set of chimeric anti-CD4 antibodies.
Alters SE; Sakai K; Steinman L; Oi VT
J Immunol; 1990 Jun; 144(12):4587-92. PubMed ID: 1972161
[TBL] [Abstract][Full Text] [Related]
2. Comparison of rat and rat-mouse chimeric anti-murine CD4 antibodies in vitro. Chimeric antibodies lyse low-density CD4+ cells.
Alters SE; Steinman L; Oi VT
J Immunol; 1989 Mar; 142(6):2018-23. PubMed ID: 2466082
[TBL] [Abstract][Full Text] [Related]
3. Comparison of GK1.5 and chimeric rat/mouse GK1.5 anti-CD4 antibodies for prolongation of skin allograft survival and suppression of alloantibody production in mice.
Rashid A; Auchincloss H; Sharon J
J Immunol; 1992 Mar; 148(5):1382-8. PubMed ID: 1538121
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the immune response to immunotoxins with anti-CD4 monoclonal antibodies.
Jin FS; Youle RJ; Johnson VG; Shiloach J; Fass R; Longo DL; Bridges SH
J Immunol; 1991 Mar; 146(6):1806-11. PubMed ID: 1672333
[TBL] [Abstract][Full Text] [Related]
5. Importance of immunoglobulin isotype in therapy of experimental autoimmune encephalomyelitis with monoclonal anti-CD4 antibody.
Waldor MK; Mitchell D; Kipps TJ; Herzenberg LA; Steinman L
J Immunol; 1987 Dec; 139(11):3660-4. PubMed ID: 3500226
[TBL] [Abstract][Full Text] [Related]
6. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T
Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
[TBL] [Abstract][Full Text] [Related]
7. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
Smith PM; Wolcott RM; Chervenak R; Jennings SR
Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of CD4+ T cell depletion on inflammatory central nervous system disease, arthritis and sialadenitis in MRL/lpr mice.
O'Sullivan FX; Vogelweid CM; Besch-Williford CL; Walker SE
J Autoimmun; 1995 Apr; 8(2):163-75. PubMed ID: 7612146
[TBL] [Abstract][Full Text] [Related]
9. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
Li J; Hu P; Khawli LA; Epstein AL
Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000
[TBL] [Abstract][Full Text] [Related]
10. In vitro antitumoral activity of baculovirus-expressed chimeric recombinant anti-CD4 antibody 13B8.2 on T-cell lymphomas.
Troadec S; Chentouf M; Cérutti M; Nguyen B; Olive D; Bès C; Chardès T
J Immunother; 2007; 30(2):190-202. PubMed ID: 17471166
[TBL] [Abstract][Full Text] [Related]
11. Synergy between an antibody and CD8+ cells in eliminating an established tumor.
Vasović LV; Dyall R; Clynes RA; Ravetch JV; Nikolić-Zugic J
Eur J Immunol; 1997 Feb; 27(2):374-82. PubMed ID: 9045907
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
[TBL] [Abstract][Full Text] [Related]
13. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
Frey AB; Cestari S
Cell Immunol; 1997 May; 178(1):79-90. PubMed ID: 9184701
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis.
Lavasani S; Dzhambazov B; Andersson M
Scand J Immunol; 2007 Jan; 65(1):39-47. PubMed ID: 17212765
[TBL] [Abstract][Full Text] [Related]
15. In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis.
Sriram S; Carroll L; Fortin S; Cooper S; Ranges G
J Immunol; 1988 Jul; 141(2):464-8. PubMed ID: 2454992
[TBL] [Abstract][Full Text] [Related]
16. Bryostatin/ionomycin-activated T cells mediate regression of established tumors.
Chin CS; Graham LJ; Hamad GG; George KR; Bear HD
J Surg Res; 2001 Jun; 98(2):108-15. PubMed ID: 11397126
[TBL] [Abstract][Full Text] [Related]
17. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment of mice with low dose anti-CD4 antibody results in a substantial antixenoantibody response and does not deplete CD4 T cells.
Jamali I; Cowdery JS
J Rheumatol; 1992 Aug; 19(8):1321-2. PubMed ID: 1357172
[No Abstract] [Full Text] [Related]
19. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
20. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.
Ye X; Robinson MB; Pabin C; Batshaw ML; Wilson JM
Gene Ther; 2000 Oct; 7(20):1761-7. PubMed ID: 11083498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
